Interactive downstream proteomics analysis with MiraProt using Mueller cell proteomes from equine recurrent uveitis

Mass spectrometry-based proteomics requires downstream analysis of processed protein abundance data, including data inspection, filtering, statistical testing, functional enrichment, protein set comparison, network analysis, and visualization. MiraProt was developed as a modular, metadata-aware R Shiny platform that integrates these steps in a single interactive workflow for processed protein-level proteomics data. Its metadata-aware design enables identifiers, sample information, experimental conditions, transformations, and derived data columns to be defined during data preparation and reused consistently across downstream analyses. To demonstrate its use, we reanalyzed a previously published label-free proteomic dataset of primary retinal Mueller cells from healthy horses and horses with equine recurrent uveitis (ERU). ERU is a naturally occurring autoimmune eye disease of horses characterized by recurrent intraocular inflammation triggered by autoreactive T-cells. Mueller cells are specialized retinal macroglia with various functions such as maintaining retinal ion homeostasis and supporting retinal neuron metabolism. Of 193 proteins with an adjusted p-value [≤] 0.05, 187 also showed at least a twofold abundance difference between ERU-derived and control Mueller cells. Functional enrichment highlighted nuclear RNA processing, chromatin-associated structures, DNA and RNA binding, interferon responses, and cell-cycle-associated programs. Gene set enrichment analysis identified positive enrichment of Interferon Alpha Response, Interferon Gamma Response, and MYC-, E2F-, and G2M-associated gene sets. Network analysis of shared proteins further linked this signature to DNA replication, mitotic checkpoint control, and RNA processing. ERU-derived Mueller cells also showed increased abundance of MHC class II-associated proteins. Together, these findings identified an interferon-responsive, cell-cycle-associated, and MHC class II-associated Mueller cell protein signature in ERU and generated experimentally testable hypotheses for further mechanistic studies. MiraProt provides an accessible, metadata-aware framework for reproducible downstream exploration of processed proteomic datasets and prioritization of candidate proteins and pathways for experimental follow-up.